Antimicrobial agents play a pivotal role in combating infectious diseases, offering a crucial line of defense against harmful microorganisms. Antibiotics, in particular, are substances derived from living organisms or synthesized chemically, designed to inhibit the growth of bacteria or destroy them altogether. They target specific cellular components or processes, disrupting bacterial functions without harming human cells. In the realm of antiviral agents, drugs like protease inhibitors and nucleoside analogs thwart the replication of viruses by targeting key enzymes. Antifungal agents, on the other hand, combat fungal infections by disrupting cell membrane synthesis or inhibiting essential enzymes. Parasitic infections are addressed through antiparasitic agents, targeting specific metabolic pathways in parasites. The emergence of antimicrobial resistance poses a significant challenge, urging the continuous exploration of novel agents and alternative therapeutic strategies. Research in this field focuses on developing innovative antimicrobial compounds, exploring combination therapies, and understanding the mechanisms behind resistance.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Mathematical modeling of COVID-19 dynamics in a West African context
Christabel Emaeyak James, University of Glasgow, United Kingdom
Title : Severe influenza and other related respiratory infection cases during Omicron era in Japan
Masafumi Seki, Saitama Medical University International Medical Center, Japan